Revisiting the WHO entity "myeloid/lymphoid neoplasms with eosinophilia and rearrangement of PDGFRA, PDGFRB or FGFR1, or with PCM1-JAK2" in 74 patients: lack of eosinophilia and presence of monocytosis

被引：0
|
作者：
Steiner, L. [1 ]
Schwaab, J. [1 ]
Naumann, N. [1 ]
Jahwar, M. [1 ]
Kreil, S. [1 ]
Haferlach, T. [2 ]
Fabarius, A. [1 ]
Hofmann, W. -K. [1 ]
Cross, N. C. P. [3 ,4 ]
Reiter, A. [1 ]
Metzgeroth, G. [1 ]
机构：
[1] Univ Med Mannheim, Med Klin 3, Hamatol & Onkol, Mannheim, Germany
[2] Munchner Leukamielab, Munich, Germany
[3] Wessex Reg Genet Lab, Salisbury, Wilts, England
[4] Univ Southampton, Fac Med, Southampton, Hants, England
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2020年 / 43卷 / SUPPL 4期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
215
引用
收藏
页码：80 / 80
页数：1
相关论文
共 35 条
  • [21] Myeloid neoplasm with eosinophilia and PCM1-JAK2 associated with acute promyelocytic leukemia with PML-RARA
    Salehi, Sajad
    Astle, John M.
    Sadigh, Sam
    Lake, Jonathan
    Aikawa, Vania
    Tang, Guilin
    Wang, Sa A.
    Bagg, Adam
    LEUKEMIA & LYMPHOMA, 2019, 60 (09) : 2299 - 2303
  • [22] Should myeloid and lymphoid neoplasms with PCM1-JAK2 and other rearrangements of JAK2 be recognized as specific entities?
    Bain, Barbara J.
    Ahmad, Shahzaib
    BRITISH JOURNAL OF HAEMATOLOGY, 2014, 166 (06) : 809 - 817
  • [23] Molecular drug targets in myeloproliferative neoplasms: mutant ABL1, JAK2, MPL, KIT, PDGFRA, PDGFRB and FGFR1
    Tefferi, Ayalew
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2009, 13 (02) : 215 - 237
  • [24] Myeloid/lymphoid neoplasms with eosinophilia and FGFR1 rearrangement t(8;13)(p11;q12): A case report and literature review
    Guo, Yu-Jie
    Ma, Meng-Xue
    Tian, Tian
    Zhang, Jing-Nan
    Guo, Xiao-Nan
    Qiao, Shukai
    ONCOLOGY LETTERS, 2024, 28 (04)
  • [25] Myeloid/lymphoid neoplasms associated with eosinophilia and rearrangements of PCM1::JAK2 with erythroblastic sarcoma: a case report and literature review
    Zhang, Lina
    Zhu, Xiaoqin
    Qu, Weiying
    Lu, Yingjia
    Feng, Zhou
    Zhao, Lin
    HAEMATOLOGICA, 2023, 108 (12) : 3506 - 3510
  • [26] Myeloid/lymphoid neoplasms associated with eosinophilia and rearrangements of PCM1::JAK2 with erythroblastic sarcoma: a case report and literature review
    Zhang, Lina
    Zhu, Xiaoqin
    Qu, Weiying
    Lu, Yingjia
    Feng, Zhou
    Zhao, Lin
    REVISTA CHILENA DE LITERATURA, 2023, (108): : 3506 - 3510
  • [27] Myeloid/lymphoid neoplasm with eosinophilia and BCR/FGFR1 rearrangement with transformation to cortical T-lymphoblastic lymphoma and erythroid precursors: a case report
    Alejandro Pineda Isaza
    Santiago Castaño Quintero
    Lisceth Paola Quintero González
    Fabián Emiliano Ahumada Córdoba
    Andrés Felipe Arbeláez Olivar
    Juan Carlos Bravo Ocaña
    Journal of Medical Case Reports, 17
  • [28] Myeloid/lymphoid neoplasm with eosinophilia and BCR/FGFR1 rearrangement with transformation to cortical T-lymphoblastic lymphoma and erythroid precursors: a case report
    Isaza, Alejandro Pineda
    Quintero, Santiago Castano
    Gonzalez, Lisceth Paola Quintero
    Cordoba, Fabian Emiliano Ahumada
    Olivar, Andres Felipe Arbelaez
    Ocana, Juan Carlos Bravo
    JOURNAL OF MEDICAL CASE REPORTS, 2023, 17 (01)
  • [29] A Phase 2 Study of Pemigatinib (FIGHT-203; INCB054828) in Patients with Myeloid/Lymphoid Neoplasms (MLNs) with Fibroblast Growth Factor Receptor 1 (FGFR1) Rearrangement (MLN FGFR1)
    Gotlib, Jason
    Kiladjian, Jean-Jacques
    Vannucchi, Alessandro
    Rambaldi, Alessandro
    Reiter, Andreas
    Shomali, William
    George, Tracy I.
    Patel, Jay L.
    Colucci, Philomena
    Walker, Chris
    Zhen, Huiling
    Verstovsek, Srdan
    BLOOD, 2021, 138
  • [30] Identification of rare recurrent FNBP1::JAK2 fusion in myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions
    Yao, Hong
    Wang, Qian
    Wang, Man
    Yan, Wanhui
    Deng, Jing
    Ding, Zixuan
    Xie, Jundan
    Zeng, Zhao
    Shen, Hongjie
    Chen, Suning
    Tang, Xiaowen
    Pan, Jinlan
    LEUKEMIA & LYMPHOMA, 2025,
1234